Verubecestat
Verubecestat (MK-8931) is an experimental drug for the treatment of Alzheimer's disease. It is an inhibitor of beta-secretase 1 (BACE1). In April 2012 phase I clinical results were announced. Phase 1b results have also been reported.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Verubecestat
Verubecestat (MK-8931) is an experimental drug for the treatment of Alzheimer's disease. It is an inhibitor of beta-secretase 1 (BACE1). In April 2012 phase I clinical results were announced. Phase 1b results have also been reported.
has abstract
Verubecestat (MK-8931) is an e ...... e was not effective in humans.
@en
CAS number
1286770-55-5
FDA UNII code
J1I0P6WT7T
KEGG
PubChem
Wikipage page ID
52,191,673
page length (characters) of wiki page
Wikipage revision ID
984,430,144
Link from a Wikipage to another Wikipage
ATC prefix
None
@en
CAS number
ChemSpiderID
31,399,364
KEGG
D10739
@en
legal status
Investigational
@en
PubChem
51,352,361
SMILES
C[C@]1c2ccNCc3cccF
@en
StdInChIKey
YHYKUSGACIYRML-KRWDZBQOSA-N
@en
synonyms
MK-8931
@en
UNII
J1I0P6WT7T
@en
wikiPageUsesTemplate
comment
Verubecestat (MK-8931) is an e ...... sults have also been reported.
@en
label
Verubecestat
@en